Ionis Pharmaceuticals Inc
IONS· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2010 | Q2 2009 |
|---|---|---|
| Revenue | $23.50M | $30.99M |
| Net Income | -$25.15M | -$2.73M |
| EPS Diluted | -$0.25 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ionis Pharmaceuticals Inc · CIK 874015 · Engraved from SEC EDGAR